Scholarly Index
Guangyan Cai
Chinese PLA General Hospital; 11,006 total citations; 432 total publications; best world rank #85
Chinese PLA General Hospital
11,006Total citations
432Total publications
55H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Renal Diseases and Glomerulopathies | Lifetime | 455 | CN 21 | 97.84 |
| Acute Kidney Injury Research | Lifetime | 369 | CN 19 | 96.34 |
| Chronic Kidney Disease and Diabetes | Lifetime | 524 | CN 24 | 97.27 |
| Dialysis and Renal Disease Management | Lifetime | 863 | CN 22 | 96.44 |
| Chemotherapy-induced organ toxicity mitigation | Lifetime | 652 | CN 22 | 82.93 |
| Clusterin in disease pathology | Lifetime | 739 | CN 71 | 51.65 |
| Antioxidants, Aging, Portulaca oleracea | Lifetime | 432 | CN 182 | 50.56 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 85 | CN 11 | 97.56 |
| Acute Kidney Injury Research | 2021-2025 | 86 | CN 10 | 95.88 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 151 | CN 21 | 96.79 |
| Renal and related cancers | 2021-2025 | 167 | CN 11 | 95.04 |
| Dialysis and Renal Disease Management | 2021-2025 | 400 | CN 29 | 93.12 |
| Renal and Vascular Pathologies | 2021-2025 | 310 | CN 9 | 87.56 |
| Mesenchymal stem cell research | 2021-2025 | 693 | CN 213 | 84.56 |
| Muscle and Compartmental Disorders | 2021-2025 | 390 | CN 42 | 65.85 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 622 | CN 32 | 60.72 |